Global Halitosis Treatment Market, By Diagnostic tests (Halimeter, Gas chromatography, BANA Test, β-galactosidase activity assay, Others), Treatment Type (Antiseptics, Antacids, Ranitidine, Cimetidine, Others), Type (Pathological Halitosis, Physiological Halitosis), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Halitosis Treatment Market Analysis and Size
The global halitosis treatment market is expected to witness significant growth during the forecast period. Halitosis is a serious issue across the globe where a reasonable case of halitosis is high, but severe cases are restricted to 5% of the population. Halimeter device helps detect low levels of sulfur whereas BANA test measures levels of a specific enzyme produced by halitosis-causing bacteria. The antacid segment is on great demand during the forecast period due to the drug’s ability to neutralize stomach acid and relieve indigestion. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global halitosis treatment market in the forecast period 2022-2029. The expected CAGR of global halitosis treatment market is tend to be around 11.0% in the mentioned forecast period. The market was valued at USD 10.93 billion in 2021, and it would grow upto USD 25.19 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Halitosis Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diagnostic tests (Halimeter, Gas chromatography, BANA Test, β-galactosidase activity assay, Others), Treatment Type (Antiseptics, Antacids, Ranitidine, Cimetidine, Others), Type (Pathological Halitosis, Physiological Halitosis), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Merck & Co., Inc. (U.S.), Cipla Inc. (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Colgate-Palmolive Company (U.S.), Rowpar Pharmaceuticals Inc. (U.S.), Reckitt Benckiser Group PLC (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Halitosis treatment is also known as bad breath and is a periodontal disease characterized by unpleasant, persistent and unattractive odour in exhaled breath. It is caused by numerous underlying conditions such as gums diseases, poor dental hygiene, lung disease, and tonsil infections. It can be detected using several devices and tests such as BANA test, halimeter, gas chromatography, and Beta-galactosidase test. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.
Global Halitosis Treatment Market Dynamics
Drivers
- Increasing Consumption of Tobacco and Alcohol
Growing consumption of tobacco and alcohol is the major factor leading to halitosis. Tobacco products and increasing risk of gum disease can also cause bad breath. For instance, according to the Tobacco Atlas, the rate of tobacco smokers is set to rise upto 24 million in Indonesia and by 7 million in Nigeria from 2015 to 2025. Tonsils, infections or inflammation in the nose, throat, or sinuses and oral cancer are other major factors that are driving halitosis treatment market growth. This boost the market growth.
- Huge Prevalence of Halitosis
Growing prevalence of halitosis is expected to boost halitosis treatment market growth. As per the records of the Bad Breath Institute study of 2018, about 35% to 45% of people all over the world suffer from bad breath at some point. In the U.S., about 80 million people spend more than US$ 10 billion annually on oral hygiene products such as mouthwashes, gum, mints, and toothpaste to combat halitosis.
Opportunities
- Surge in usage in Hospitals
Hospitals and specialty clinics are the biggest consumer of the leukemia treatment market and it is growing because of the development of more and more hospitals. In addition to this, healthcare companies are also launching new and improved formulations of drugs for lowering the basal cell carcinoma cases.
- Rising Gastrointestinal Disorders
Cancers, liver failure, and other metabolic diseases can also cause halitosis, because of the production of specific mixtures of chemicals such as ketones. Gastrointestinal diseases which includes pharyngeal pouches, pyloric stenosis, duodenal obstruction, aorto-enteric anastomosis, and zenker's diverticulum are also some other major factors causing halitosis finally driving the halitosis treatment market growth. This creates more opportunity in the market.
Restraints/Challenges
- Lack of Awareness
Lack of awareness among the general people of developing economies may hinder the halitosis treatment market growth. Most gums, mints, and mouthwashes merely mask the odours of the sulphur compounds and sugars in most mints and gums that can cause the bacteria to multiply faster.
- High Cost
The huge expenditure of the treatment methods surely hamper the market growth. The treatment types such as antiseptics, antacids, ranitidine, cimetidine are increasing their market prices abnd as a result, the market is getting hampered.
This global halitosis treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global halitosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Halitosis Treatment Market Scope
The global halitosis treatment market is segmented on the basis of diagnostic tests, treatment type, type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnostic Tests
- Halimeter
- Gas chromatography
- BANA Test
- β-galactosidase activity assay
- Others
Treatment Type
- Antiseptics
- Antacids
- Ranitidine
- Cimetidine
- Others
Type
- Pathological Halitosis
- Physiological Halitosis
End-Users
- Hospitals
- Homecare
- Speciality Centres
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Halitosis Treatment Market Regional Analysis/Insights
The global halitosis treatment market is analysed and market size insights and trends are provided by treatment type, type, distribution channel and end-user as referenced above.
The major countries covered in the global halitosis treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is expected to have the highest market growth due to the rise cases of gum diseases, vulnerable geriatric population, favourable government policies, and advanced healthcare facilities.
Asia-Pacific dominates the market due to the increase government initiatives and rapidly increasing disposable income.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Halitosis Treatment Market Share Analysis
The global halitosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global halitosis treatment market.
Key players operating in the global halitosis treatment market include:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Merck & Co., Inc. (U.S.)
- Cipla Inc. (U.S.)
- Abbott (U.S.)
- AbbVie Inc. (U.S.)
- Lupin (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Colgate-Palmolive Company (U.S.)
- Rowpar Pharmaceuticals Inc. (U.S.)
- Reckitt Benckiser Group PLC (U.K.)
SKU-